Bright Oxygen And Acetylene Co Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
- Paid Up Capital ₹ 4.61 M
- Company Age 51 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Bright Oxygen And Acetylene Co
Bright Oxygen And Acetylene Co Private Limited (BOAACPL) was founded in India on 30 April 1973 and has a glorious history of 51 years and nine months.Its registered office is in New Delhi, India.
The Corporate was formerly known as Bright Oxygen And Acetylene Co Limited. The Company is engaged in the Oil & Gas Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 4.61 M, as per Ministry of Corporate Affairs (MCA) records.
Nimesh Bansal, Madhulika Bansal, and Rathik Bansal serve as directors at the Company.
Company Details
- Location
New Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U23201DL1973PTC006590
- Company No.
006590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 1973
- Date of AGM
14 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Bright Oxygen And Acetylene Co?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhulika Bansal  | Managing Director | 21-Sep-1998 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rathik Bansal | Director | 28-Jan-2010 | Current |
| Nimesh Bansal | Director | 07-Dec-2007 | Current |
Financial Performance of Bright Oxygen And Acetylene Co.
Bright Oxygen And Acetylene Co Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bright Oxygen And Acetylene Co?
In 2017, Bright Oxygen And Acetylene Co had a promoter holding of 98.59% and a public holding of 1.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bright Oxygen And Acetylene Co?
Bright Oxygen And Acetylene Co has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bright Oxygen And Acetylene Co, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bright Oxygen And Acetylene Co's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
